Performance analysis of Merrimack Pharmaceuticals (MACK)
Annual Return
Over the past 3 years, MACK has had an average annual return of +143.79%, outperforming the benchmark SPY, which returned +26.42% annual.
Over the past 5 years, MACK has had an average annual return of +68.96%, outperforming the benchmark SPY, which returned +9.56% annual.
Over the past 10 years, MACK has had an average annual return of +2.03%, underperforming the benchmark SPY, which returned +14.19% annual.
Since Mar 29, 2012, MACK has had an average annual return of +2.29%, underperforming the benchmark SPY, which returned +13.59% annual.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +125.43% | +17.02% | +193.08% | -43.26% | +118.72% | +48.59% | -62.33% | -63.69% | -48.35% | -30.09% | +111.98% | -12.47% |
| 2012 | |||||||||||
| +0.83% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -0.07% | +9.69% | +0.48% | -0.22% | +105.11% | +125.43% | |||||||
| 2023 | +1.14% | -0.95% | +7.06% | +0.97% | +0.89% | -1.76% | -2.35% | +1.66% | +0.98% | -0.80% | +3.19% | +6.25% | +17.02% |
| 2022 | +32.45% | +20.47% | +1.36% | -8.27% | -10.72% | +14.89% | -14.46% | -18.44% | -9.67% | +0.55% | +215.89% | -3.78% | +193.08% |
| 2021 | -2.50% | -3.55% | -3.08% | +12.24% | -9.21% | -0.14% | -12.39% | -10.33% | -3.79% | -10.97% | -2.35% | -6.89% | -43.26% |
| 2020 | -2.55% | -5.90% | -25.58% | +71.61% | -8.15% | -1.76% | -0.28% | +24.40% | -3.17% | -3.50% | +1.55% | +75.82% | +118.72% |
| 2019 | +43.72% | +10.09% | +13.75% | -5.89% | -10.42% | +3.28% | +1.45% | +2.11% | +15.73% | -12.27% | -8.34% | -1.65% | +48.59% |
| 2018 | +2.41% | +5.81% | -27.54% | +5.35% | +3.40% | -43.99% | +5.28% | +14.55% | -10.02% | -26.98% | +12.35% | -11.66% | -62.33% |
| 2017 | -23.77% | -1.28% | +0.31% | +8.12% | -21.22% | -31.68% | +7.25% | +2.26% | +6.91% | -19.26% | -1.53% | -11.32% | -63.69% |
Drawdown analysis of Merrimack Pharmaceuticals (MACK)
The maximum drawdown for the MACK was -96.86%, occurring on Mar 20, 2020. This drawdown has not yet recovered.
The current MACK drawdown is -41.79%.
Since Mar 29, 2012 MACK has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 3 times
- 20% or more: 4 times
- 10% or more: 6 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.86% | Apr 23, 2015 | 1236 | Mar 20, 2020 | Ongoing | Ongoing | Ongoing |
| -81.19% | Sep 24, 2012 | 281 | Nov 6, 2013 | 282 | Dec 19, 2014 | 563 |
| -34.60% | Apr 19, 2012 | 32 | Jun 5, 2012 | 35 | Jul 25, 2012 | 67 |
| -25.91% | Jan 8, 2015 | 18 | Feb 4, 2015 | 20 | Mar 5, 2015 | 38 |
| -16.57% | Jul 25, 2012 | 20 | Aug 22, 2012 | 19 | Sep 19, 2012 | 39 |
| -10.82% | Mar 5, 2015 | 14 | Mar 25, 2015 | 12 | Apr 13, 2015 | 26 |
| -4.44% | Dec 19, 2014 | 2 | Dec 23, 2014 | 2 | Dec 26, 2014 | 4 |
| -4.36% | Apr 16, 2015 | 2 | Apr 20, 2015 | 2 | Apr 22, 2015 | 4 |
| -3.06% | Mar 30, 2012 | 1 | Apr 2, 2012 | 4 | Apr 9, 2012 | 5 |
| -2.66% | Jan 5, 2015 | 1 | Jan 6, 2015 | 2 | Jan 8, 2015 | 3 |
| -1.16% | Dec 29, 2014 | 1 | Dec 30, 2014 | 1 | Dec 31, 2014 | 2 |
| -0.85% | Apr 12, 2012 | 1 | Apr 13, 2012 | 1 | Apr 16, 2012 | 2 |
| -0.70% | Apr 13, 2015 | 1 | Apr 14, 2015 | 1 | Apr 15, 2015 | 2 |